Prof. Harald Renz Philipps-University Marburg, Germany
1 Talk
Biography
Prof. Harald Renz is director and chairman of the Institute of Laboratory Medicine and Pathobiochemistry of the Philipps-University Marburg, Germany. He holds this position since 1999. From 2005 to 2014 he coordinated the inter-regional Research Consortium of Allergies and Asthma, which is funded by the German Research Council; since 2010 he serves as vice-speaker of the Universities of Giessen and Marburg Lung Center (UGMLC), which is one out of 5 sites of the German Lung Center, founded 2012 by the Federal Government. His research interest is the pathogenesis of allergies and asthma. He has made major contributions in the field of the origin of asthma, with regard to the pre- and postnatal environment. 2012/13 he was Visiting Professor and Fulbright Scholar at Harvard Medical School in Boston. Since 2010 he serves as Associated Editor of the Journal of Allergy and Clinical Immunology (JACI, IF 12.5). Since 2015 he is Medical Director and CMO of the University Hospital Giessen and Marburg GmbH, Campus Marburg. From 2010 to 2016 he was President of the German Society of Allergy and Clinical Immunology (DGAKI) and since 2016 he is Past President of the German Society of Allergy and Clinical Immunology.
To use this function, you need to be signed in
with a personal account.
If you already have a personal account, please
login here.
Otherwise you may sign up now
for a personal account.
Cookies and Privacy
We use cookies, and similar tools, to improve the way this site functions, to
track browsing patterns and enable marketing. For more information read our
cookie policy and
privacy policy.
Some types of cookies can be disabled by you but doing so may adversely
affect functionality. Please see below:
(always on)
If you block these cookies or set alerts in your browser parts
of the website will not work.
Cookies that provide enhanced functionality and personalisation. If not
allowed functionality may be impaired.
Cookies that count and track visits and on website activity enabling us
to organise the website to optimise the experience of users. They may be
blocked without immediate adverse effect.